Association of Vancomycin Trough Concentration and Clearance With Febrile Neutropenia in Pediatric Patients.
Erino AmanoRyota TanakaHiroyuki OnoRyosuke TatsutaTakehiro HashimotoKazufumi HiramatsuHiroki ItohPublished in: Therapeutic drug monitoring (2022)
Increased initial dosage and therapeutic drug monitoring-guided dose optimization are critical for the therapeutic efficacy of vancomycin in pediatric patients with febrile neutropenia, especially in those aged 1-6 years.